PulmoBioMed raised €1.6M in a funding round in Feb 2024. The company is based in Newcastle upon Tyne, UK. Investors in the round: North East Venture Fund, SFC Capital. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
